March-In Rights Likely A Slow Trot at Best | Capitol Street

Published On: 02/08/2022 ▪

March-In Rights Likely A Slow Trot at Best

Xtandi’s High US Price Reinvigorates Government IP Rights Debate

Access memo here

View More Posts

CO Drug Board Looks to Price Caps For 2024
Published On: 09/01/2023
Top 10 Drug List for Negotiation
Published On: 08/29/2023
2024 GOP Candidates on Healthcare
Published On: 08/23/2023
Getting Ready for the List
Published On: 08/21/2023
Leqembi Does Not Meet Significant Cost for MA
Published On: 08/18/2023
New v28 MA Model Applies to ACO REACH 2024
Published On: 08/14/2023
Novitas & First Coast Oncology Genetic Testing LCD
Published On: 08/10/2023
2023 State PBM Report Card
Published On: 08/07/2023
MedTech Policies in Final Inpatient Rule
Published On: 08/01/2023
Inpatient Hospital 2024 Pay: +3.8% Final
Published On: 08/01/2023

What insights can we share with you?

Contact Info

900 19th Street Northwest
Washington, DC 20006
United States
team@capitol-street.com

PastedGraphic-26